Inovio Pharmaceuticals (INO) Change in Account Payables (2010 - 2022)

Inovio Pharmaceuticals has reported Change in Account Payables for 13 years, with the latest figure at $859354.0 in Q1 2022.

• Quarterly Change in Account Payables rose 585.88% year-over-year to $859354.0 in Q1 2022, while the trailing twelve-month figure through Mar 2022 was $639125.0 (down 12.11% YoY) and the FY2021 annual result came in at -$94937.0, down 169.99% from the prior year.
• Change in Account Payables advanced to $859354.0 in Q1 2022 per INO's latest filing, from $56387.0 in the prior quarter.
• Over five years, Change in Account Payables peaked at $1.0 million in Q2 2021 and troughed at -$1.3 million in Q3 2021.
• A 5-year average of $41344.3 and a median of $125292.0 in 2021 frame the typical range for Change in Account Payables.
• The sharpest annual moves came in 2021 and 2022: Change in Account Payables slumped 553.11% in 2021, then jumped 585.88% in 2022.
• Over 5 years, Change in Account Payables stood at $286872.0 in 2018, then retreated by 6.88% to $267133.0 in 2019, then tumbled by 156.89% to -$151959.0 in 2020, then jumped by 137.11% to $56387.0 in 2021, then surged by 1424.03% to $859354.0 in 2022.
• According to Business Quant data, Change in Account Payables over the past three periods registered $859354.0, $56387.0, and -$1.3 million for Q1 2022, Q4 2021, and Q3 2021 respectively.